EAM
Eventide Asset Management Portfolio holdings
AUM
$6.05B
1-Year Est. Return
76.64%
This Fund
S&P 500
1 Year Est. Return
+76.64%
AUM
$6.05B
AUM Growth
-$355M
(-5.5%)
Holding
314
Top Buys
| 1 | +$41.9M | |
| 2 | +$40.9M | |
| 3 | +$24.8M | |
| 4 |
Teradyne
TER
|
+$24.8M |
| 5 |
UL Solutions
ULS
|
+$21.1M |
Top Sells
| 1 | +$64.4M | |
| 2 | +$42.1M | |
| 3 | +$40.6M | |
| 4 |
RNAM
Avidity Biosciences
RNAM
|
+$37.8M |
| 5 |
Lithia Motors
LAD
|
+$33.8M |
Sector Composition
| 1 | Healthcare | 39.12% |
| 2 | Industrials | 19.41% |
| 3 | Technology | 15.63% |
| 4 | Energy | 7.14% |
| 5 | Consumer Discretionary | 5.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Pool Corp
POOL
$6.73B
| – | – |
-2,190
|
|
||
302
uniQure
QURE
$1.53B
| – | – |
-498,212
|
|
||
303
Rambus
RMBS
$15.5B
| – | – |
-10,330
|
|
||
|
RNAM
304
DELISTED
Avidity Biosciences
RNAM
| – | – |
-524,643
|
|
||
305
Syndax Pharmaceuticals
SNDX
$1.77B
| – | – |
-1,238,196
|
|
||
306
TG Therapeutics
TGTX
$5.95B
| – | – |
-716,414
|
|
||
307
Trade Desk
TTD
$10.5B
| – | – |
-137,471
|
|
||
308
Veracyte
VCYT
$3.59B
| – | – |
-570,720
|
|
||
309
VF Corp
VFC
$6.54B
| – | – |
-21,864
|
|
||
310
Verisk Analytics
VRSK
$22.4B
| – | – |
-48,002
|
|
||
311
Wayfair
W
$8.85B
| – | – |
-4,315
|
|
||
312
Wave Life Sciences
WVE
$1.23B
| – | – |
-500,000
|
|
||
|
NBIS
313
Nebius Group N.V.
NBIS
$54.5B
| – | – |
-18,491
|
|
||
|
MAZE
314
Maze Therapeutics
MAZE
$1.43B
| – | – |
-324,041
|
|